Plain-English translation of NCT07481149 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a virtual exercise-based rehabilitation program called EX-CIPN can help cancer survivors who are experiencing persistent nerve damage and pain from chemotherapy. Half of the participants will receive the exercise program with coaching support, while the other half will receive usual care and can access the program after the study ends. The goal is to find out whether this remote exercise program helps reduce symptoms and improves daily functioning.
Many cancer survivors experience lasting nerve damage and pain after chemotherapy finishes, which can make everyday activities difficult. This trial exists to see whether a structured, personalized exercise program delivered remotely can safely and effectively reduce these symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll attend assessments at the start, immediately after the program, and 3 months later. If you're in the exercise group, you'll complete a personalized 10-week virtual exercise program from home, receive coaching calls from your care team on weeks 2, 3, 4, 6, and 8, and wear a FitBit to track your daily activity. The control group will receive usual cancer follow-up care and can access the exercise program after the study is complete.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Canada